Effects of dehydroepiandrosterone supplementation on clinical outcomes and cumulus cells gene expression in women with poor ovarian response
博士 === 國立中山大學 === 生物科學系研究所 === 103 === The aim of the study was to investigate the effects of dehydroepiandrosterone (DHEA) supplementation on IVF (In vitro fertilization) outcomes and the gene expression of cumulus cells (CCs) in patients with poor ovarian response (POR). This was a prospective sel...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/s56wv9 |
id |
ndltd-TW-103NSYS5112026 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-103NSYS51120262019-05-15T22:17:49Z http://ndltd.ncl.edu.tw/handle/s56wv9 Effects of dehydroepiandrosterone supplementation on clinical outcomes and cumulus cells gene expression in women with poor ovarian response 卵巢反應不佳的婦女補充脫氫表雄酮對臨床預後及卵丘細胞基因表現的影響 Kuan-Hao Tsui 崔冠濠 博士 國立中山大學 生物科學系研究所 103 The aim of the study was to investigate the effects of dehydroepiandrosterone (DHEA) supplementation on IVF (In vitro fertilization) outcomes and the gene expression of cumulus cells (CCs) in patients with poor ovarian response (POR). This was a prospective self-controlled study, including ten patients with POR. All women received DHEA supplementation (30 mg, t.i.d.) for around 3 months before starting the a new IVF cycle. Biochemical, ultrasound parameters and treatment outcomes were determined before and after DHEA therapy. Moreover, CCs were isolated to examine the gene expression level of nine genes, including Hyaluronan synthase (HAS2), Versican (VCAN), Thrombospondin 1 (THBS1), Runt-related transcription factor 2 (RUNX2), Chromobox homolog 3 (CBX3), Tripartite motif-containing 28 (TRIM28), B-cell lymphoma 2 (BCL2), BCL2-associated X protein (BAX), Ankyrin repeat domain 57 (ANKRD57), Syndecan 4 (SDC4), Activated leukocyte cell adhesion molecule (ALCAM), Gremlin 1 (GREM1), Prostaglandin-endoperoxide synthase 1 (PTGS1), Prostaglandin-endoperoxide synthase 2 (PTGS2), Sprouty homolog 4 (SPRY4), Coagulation factor II receptor-like 1 (F2RL1), Ribosomal protein S6 kinase, polypeptide 2 (RPS6KA2), solute carrier family 38, member 2 (SLC38A2), YTH domain family,member 2 (YTHDF2), Cytochrome oxidase 17 (COX17), E3 ubiquitin protein ligase (UBR3), Krueppel-like factor 4 (KLF4), prostaglandin E receptor 2 (PTGER2), exostoses 1 (EXT1) by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). It showed significant changes in day 3 follicle-stimulating hormone (FSH), estradiol, antral follicle count (AFC) and Anti-Müllerian Hormone (AMH) (p < 0.0001, < 0.0001, < 0.05 and < 0.001, respectively), as well as number of oocytes retrieved, fertilized oocytes, day 3 embryos, transferred embryos (p < 0.0001, < 0.0001, < 0.05 and < 0.001, respectively) after DHEA therapy. In addition, the gene expression levels of extracellular matrix (ECM), including HAS2, VCAN, THBS1, showed significant increase after DHEA treatment. Although the gene expression levels of BCL2 and BAX, which are apoptotic genes, showed decrease; however, BCL2/BAX ratio elevated significantly, suggested that DHEA may play a role in anti-apoptosis. The study demonstrated that DHEA shows benefit for artificial reproductive outcomes and upregulates the gene expression of CCs in POR patients. Cheng Jiin-Tsuey 陳錦翠 2015 學位論文 ; thesis 115 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
博士 === 國立中山大學 === 生物科學系研究所 === 103 === The aim of the study was to investigate the effects of dehydroepiandrosterone (DHEA) supplementation on IVF (In vitro fertilization) outcomes and the gene expression of cumulus cells (CCs) in patients with poor ovarian response (POR). This was a prospective self-controlled study, including ten patients with POR. All women received DHEA supplementation (30 mg, t.i.d.) for around 3 months before starting the a new IVF cycle. Biochemical, ultrasound parameters and treatment outcomes were determined before and after DHEA therapy. Moreover, CCs were isolated to examine the gene expression level of nine genes, including Hyaluronan synthase (HAS2), Versican (VCAN), Thrombospondin 1 (THBS1), Runt-related transcription factor 2 (RUNX2), Chromobox homolog 3 (CBX3), Tripartite motif-containing 28 (TRIM28), B-cell lymphoma 2 (BCL2), BCL2-associated X protein (BAX), Ankyrin repeat domain 57 (ANKRD57), Syndecan 4 (SDC4), Activated leukocyte cell adhesion molecule (ALCAM), Gremlin 1 (GREM1), Prostaglandin-endoperoxide synthase 1 (PTGS1), Prostaglandin-endoperoxide synthase 2 (PTGS2), Sprouty homolog 4 (SPRY4), Coagulation factor II receptor-like 1 (F2RL1), Ribosomal protein S6 kinase, polypeptide 2 (RPS6KA2), solute carrier family 38, member 2 (SLC38A2), YTH domain family,member 2 (YTHDF2), Cytochrome oxidase 17 (COX17), E3 ubiquitin protein ligase (UBR3), Krueppel-like factor 4 (KLF4), prostaglandin E receptor 2 (PTGER2), exostoses 1 (EXT1) by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). It showed significant changes in day 3 follicle-stimulating hormone (FSH), estradiol, antral follicle count (AFC) and Anti-Müllerian Hormone (AMH) (p < 0.0001, < 0.0001, < 0.05 and < 0.001, respectively), as well as number of oocytes retrieved, fertilized oocytes, day 3 embryos, transferred embryos (p < 0.0001, < 0.0001, < 0.05 and < 0.001, respectively) after DHEA therapy. In addition, the gene expression levels of extracellular matrix (ECM), including HAS2, VCAN, THBS1, showed significant increase after DHEA treatment. Although the gene expression levels of BCL2 and BAX, which are apoptotic genes, showed decrease; however, BCL2/BAX ratio elevated significantly, suggested that DHEA may play a role in anti-apoptosis. The study demonstrated that DHEA shows benefit for artificial reproductive outcomes and upregulates the gene expression of CCs in POR patients.
|
author2 |
Cheng Jiin-Tsuey |
author_facet |
Cheng Jiin-Tsuey Kuan-Hao Tsui 崔冠濠 |
author |
Kuan-Hao Tsui 崔冠濠 |
spellingShingle |
Kuan-Hao Tsui 崔冠濠 Effects of dehydroepiandrosterone supplementation on clinical outcomes and cumulus cells gene expression in women with poor ovarian response |
author_sort |
Kuan-Hao Tsui |
title |
Effects of dehydroepiandrosterone supplementation on clinical outcomes and cumulus cells gene expression in women with poor ovarian response |
title_short |
Effects of dehydroepiandrosterone supplementation on clinical outcomes and cumulus cells gene expression in women with poor ovarian response |
title_full |
Effects of dehydroepiandrosterone supplementation on clinical outcomes and cumulus cells gene expression in women with poor ovarian response |
title_fullStr |
Effects of dehydroepiandrosterone supplementation on clinical outcomes and cumulus cells gene expression in women with poor ovarian response |
title_full_unstemmed |
Effects of dehydroepiandrosterone supplementation on clinical outcomes and cumulus cells gene expression in women with poor ovarian response |
title_sort |
effects of dehydroepiandrosterone supplementation on clinical outcomes and cumulus cells gene expression in women with poor ovarian response |
publishDate |
2015 |
url |
http://ndltd.ncl.edu.tw/handle/s56wv9 |
work_keys_str_mv |
AT kuanhaotsui effectsofdehydroepiandrosteronesupplementationonclinicaloutcomesandcumuluscellsgeneexpressioninwomenwithpoorovarianresponse AT cuīguānháo effectsofdehydroepiandrosteronesupplementationonclinicaloutcomesandcumuluscellsgeneexpressioninwomenwithpoorovarianresponse AT kuanhaotsui luǎncháofǎnyīngbùjiādefùnǚbǔchōngtuōqīngbiǎoxióngtóngduìlínchuángyùhòujíluǎnqiūxìbāojīyīnbiǎoxiàndeyǐngxiǎng AT cuīguānháo luǎncháofǎnyīngbùjiādefùnǚbǔchōngtuōqīngbiǎoxióngtóngduìlínchuángyùhòujíluǎnqiūxìbāojīyīnbiǎoxiàndeyǐngxiǎng |
_version_ |
1719127772654206976 |